As part of our continuing series of evaluations, we take a look at two point-of-care (POC) HbA1c analyzers. As standards on performance have tightened, have POC devices kept up? Has their improved performance matched the higher demands?
A chance to get a second look at instrument performance. In 2011, CCLM had a study of performance of the Menarini/ARKRAY ADAMS A1c HA-8180V analyzer. In 2012, Lab Med Online has another study, which gives us another opportunity to see if the first findings hold up.
In a 2011 study, an India hospital laboratory undertook a quality assessment of their clinical chemistry methods using Sigma-metrics. Is laboratory method quality the same the world over?
A 2011 study performed analysis on the performance of cancer markers on the Siemens Vista. We use the data and calculate Sigma-metrics. How good do cancer marker assays need to be? Are new methods meeting those goals?